ClinicalTrials.Veeva

Menu

A Predictive Score for the Ischemic Etiology of a Transient Diplopia (VASCO-DIP)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Enrolling

Conditions

Diplopia

Treatments

Other: Clinical, ophthalmological and neurological evaluation

Study type

Observational

Funder types

NETWORK

Identifiers

NCT02576925
MOA_2015-7

Details and patient eligibility

About

The transient diplopias (TD) is defined by a short diplopia. Their etiology may be ophthalmological, neurological non-ischemic or of ischemic origin.

The difficulty is to recognize an ischemic mechanism which imposes emergency cares.

A clinical score could help the clinician to recognize the etiology of the TD .

Enrollment

220 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Transient diplopia (i.e. less than 24 hours) during the last 8 days

Exclusion criteria

Trial design

220 participants in 1 patient group

Eligible patients
Description:
Adults having had a transient diplopia during the last 8 days.
Treatment:
Other: Clinical, ophthalmological and neurological evaluation

Trial contacts and locations

2

Loading...

Central trial contact

Michel Rosenheim, MD, DSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems